Related Experiment Video
Updated: Jul 27, 2026

Experimental Metastasis Assay
Published on: August 24, 2010
Molecular pathology of tumor metastasis. I. Predictive pathology
1Department of Tumor Progression, National Institute of Oncology, Ráth Gy. U. 7-9., Budapest, H-1122 Hungary. jtimar@oncol.hu
Abstract:
Millennium reviews of oncology agreed that the last century produced major developments mainly in the management of the primary tumor, but despite all of these results, cancer still remains among the leading causes of death due to the failure of clinical management of disseminated disease. This failure is primarily due to the lack of detailed information on the molecular mechanisms of tumor metastasis. Therefore, one of the hottest fields in experimental oncology is metastasis research, which provides more and more information about the molecular mechanisms. However, this information is fragmented and is not yet exploited in clinical practice. A new field of diagnostic pathology recently emerged, which translates basic research data to diagnostic practice to provide clinically relevant information on the biological potential (in this case metastatic potential) of the malignant tumors. Since tumor cell-extracellular matrix interactions are key features of tumor dissemination, expression of genes responsible for them can define the metastatic potential of malignant tumors. This review summarizes our recent knowledge on the metastatic geno- and phenotype of major human solid tumors: lung, colon, breast, prostate cancers and malignant melanoma.
Insights
Understanding cancer metastasis is crucial for improving patient outcomes. Research into the molecular mechanisms of tumor spread and diagnostic pathology can enhance the clinical management of disseminated cancer.
Area of Science:
- Oncology
- Molecular Biology
- Diagnostic Pathology
Background:
- Despite advances in primary tumor management, disseminated cancer remains a leading cause of death.
- Lack of understanding of molecular mechanisms driving tumor metastasis hinders clinical progress.
- Metastasis research is a key focus in oncology, generating fragmented but vital molecular data.
Purpose of the Study:
- To review current knowledge on the metastatic genotype and phenotype of major human solid tumors.
- To highlight the role of tumor cell-extracellular matrix interactions in tumor dissemination.
- To bridge basic research findings with diagnostic pathology for clinical application.
Main Methods:
- Literature review of metastasis research in oncology.
- Analysis of gene expression related to tumor cell-extracellular matrix interactions.
- Synthesis of data on metastatic potential in lung, colon, breast, prostate cancers, and melanoma.
Main Results:
- Tumor cell-extracellular matrix interactions are critical determinants of metastatic potential.
- Gene expression profiles can define the metastatic capabilities of malignant tumors.
- Fragmented molecular data on metastasis is increasingly available.
Conclusions:
- Translational diagnostic pathology can leverage basic research for clinical insights.
- Understanding metastatic mechanisms is essential for improving cancer treatment strategies.
- Further integration of molecular data into clinical practice is needed for managing metastatic disease.
Related Concept Videos
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

